Results of a landmark international study in this week's issue of THE LANCET provide compelling evidence for the use of a platinum coil transported through blood vessels--rather than conventional ...
A landmark clinical trial led by UK researchers has shown that patients who suffer a brain haemorrhage from a ruptured aneurysm[1] have a significantly better chance of surviving without disability if ...
Aliso Viejo, CA, May 14, 2026 (GLOBE NEWSWIRE) -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced the publication of ...
On Wednesday, Alzamend Neuro, Inc. (NASDAQ:ALZN) announced it had completed the head coil by Tesla Dynamic Coils BV. The development of the head coil was necessary to facilitate Alzamend's five ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Today Penumbra, Inc. announced the US launch of the Penumbra Coil 400, a stretch-resistant, platinum embolic coil that has a 400% volume filling advantage compared to ...
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy, Alzheimer’s disease, ...
PESHAWAR: Local doctors, in collaboration with a US-based Pakistani neurosurgeon, have successfully performed brain aneurysm coiling, a modern neuro-endovascular procedure, at the Lady Reading ...
The risks associated with treating a recurrent or residual brain aneurysm that was initially treated by endovascular coiling are low, according to a multicenter study. The risks associated with ...
ATLANTA - Alzamend Neuro , Inc. (NASDAQ:ALZN), a micro-cap biopharmaceutical company with a market value of $5.92 million engaged in developing treatments for neurological disorders and mental health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results